1832 Asset Management L.P. Penumbra Inc Transaction History

1832 Asset Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$131.82 - $183.4 $1.73 Million - $2.4 Million	-13,100 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$124.65 - $167.39 $1.63 Million - $2.19 Million	13,100 New	13,100 $2.1 Million
Q1 2019 May 15, 2019	SELL	$115.84 - $160.31 $45 Million - $62.3 Million	-388,600 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$113.42 - $156.48 $44.1 Million - $60.8 Million	388,600 New	388,600 $46.3 Million
Q3 2018 Nov 14, 2018	SELL	$121.55 - $156.8 $42.1 Million - $54.3 Million	-346,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$112.2 - $165.95 $38.9 Million - $57.5 Million	346,500 New	346,500 $46.7 Million

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.26B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.